Gene · 5154
Papers4,148
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 4,148
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic Potential of Tyrosine Kinase Inhibitors in Advanced Thyroid Cancer. | Curr Oncol Rep | 2026 | 41642503 | PubTator, text mining | PubMed |
| Polystyrene nanoplastics exacerbate dibutyl phthalate-induced liver fibrosis through PDGFRα-dependent hepatic stellate cell activation. | Environ Pollut | 2026 | 41638286 | PubTator, text mining | PubMed |
| Vascular remodelling and fibrotic changes in the joint capsule during periprosthetic knee infections. | Bone Joint Res | 2026 | 41633392 | PubTator, text mining | PubMed |
| Mechanistic insights into PCBP1-driven unfolding of selected i-motif DNA at G1/S checkpoint. | Nat Commun | 2026 | 41629296 | PubTator, text mining | PubMed |
| Microglial GPR35 Ameliorates Epileptogenesis and Neuroinflammation via PDGFA Domain 2 Signaling. | Adv Sci (Weinh) | 2026 | 41604576 | PubTator, text mining | PubMed |
| The purinergic signaling interfaces in breast cancer angiogenesis. | Purinergic Signal | 2026 | 41575692 | PubTator, text mining | PubMed |
| BCOR mutations define a therapeutic vulnerability to DHODH Inhibition in acute myeloid leukemia. | Ann Hematol | 2026 | 41549155 | PubTator, text mining | PubMed |
| Platelet-rich fibrin-derived extracellular vesicles: emerging biological mediators in periodontal regeneration. | Odontology | 2026 | 41350499 | PubTator, text mining | PubMed |
| Large-Scale Blood Proteomic Analysis Across Different Inflammatory Skin Conditions Reveals Extensive Immune Dysregulation With Distinct Biomarker Profiles. | Allergy | 2026 | 41246813 | PubTator, text mining | PubMed |
A biomimetic folding paper co-culture system for analyzing cellular crosstalk in bone healing: Interactions of bone morphogenetic protein-2, Wnt family member 1, periostin, and platelet-derived growth factor subunit A between periosteum-derived progenitor cells and adipose-derived stem cells. | Talanta | 2026 | 41045659 | PubTator, text mining | PubMed |
| Redistribution of super-enhancers promotes malignancy in human hepatocellular carcinoma. | J Adv Res | 2026 | 40617410 | PubTator, text mining | PubMed |
| THBS1 as a candidate biomarker and fibrotic mediator in radiation-induced liver injury: insights from TMT-labeled quantitative proteomics. | Front Pharmacol | 2025 | 41394148 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals MCAM+ MyCAFs as key pro-angiogenic cells interacting with endothelial cells in solid-type adenoid cystic carcinoma. | Cancer Cell Int | 2025 | 41361749 | PubTator, text mining | PubMed |
| A New Approach for Achieving Earlier and More Accurate Diagnosis of Connective Tissue Disease-Related Interstitial Lung Disease: TGFB and PDGFA as Novel Promising Biomarkers. | Int J Mol Sci | 2025 | 41226758 | PubTator, text mining | PubMed |
| IGF2BP2 stabilized by USP7 promotes cancer-associated fibroblast activation and attenuates gemcitabine sensitivity in PDAC. | Cell Rep | 2025 | 41201091 | PubTator, text mining | PubMed |
| Advances in Molecular and Translational Medicine: 2nd Edition. | Int J Mol Sci | 2025 | 41096897 | PubTator, text mining | PubMed |
| An Integrative Genotyping and Gene Expression Profiling of the Mutated Human FAM111B Gene and Fibrosis-Associated Pathway in the POIKTMP Syndrome. | J Cell Mol Med | 2025 | 41053916 | PubTator, text mining | PubMed |
| HCV patients with residual fibrosis after DAA treatment re-establish their epigenetic signature after prolonged-release pirfenidone: MINERVA study. | Clin Epigenetics | 2025 | 41044745 | PubTator, text mining | PubMed |
| Innovations, Challenges, and Regulatory Pathways in Cultured Meat for a Sustainable Future. | Foods | 2025 | 41008156 | PubTator, text mining | PubMed |
| White Matter in Crisis: Oligodendrocytes and the Pathophysiology of Multiple Sclerosis. | Cells | 2025 | 41002375 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5154/papers?page=3